Pegylated recombinant uricase (Hangzhou Grand Biologic)
聚乙二醇化尿酸酶（杭州远大生物）
Report date: 2026/05/15 20:01:45
Base Information
Drug NamePegylated recombinant uricase (Hangzhou Grand Biologic)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesChongqing Peg-Bio Biopharm Co LtdHangzhou Longda Xinke Bio-Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A